Try it
Biochemistry · Lipid metabolism: 5-lipoxygenase and leukotrienes
Sample itemA drug used in asthma reduces synthesis of the leukotrienes LTC4, LTD4 and LTE4 by inhibiting an enzyme of arachidonic acid metabolism. Which enzyme does it inhibit?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
D. 5-Lipoxygenase
Arachidonic acid is converted by 5-lipoxygenase to LTA4, the precursor of LTB4 and the cysteinyl leukotrienes LTC4, LTD4 and LTE4. These cause bronchoconstriction and mucus secretion and were once called the slow-reacting substance of anaphylaxis. Zileuton inhibits 5-lipoxygenase, while montelukast blocks the cysteinyl leukotriene receptor.
Option by option
A. Thromboxane synthase
Thromboxane synthase makes thromboxane A2 from the prostaglandin endoperoxide.
B. Phospholipase A2
Phospholipase A2 releases arachidonic acid for both pathways, so inhibiting it would not be selective for leukotrienes.
C. Cyclooxygenase-2
Cyclooxygenase-2 makes prostaglandins, not leukotrienes.
D. 5-Lipoxygenase (correct)
Correct. 5-Lipoxygenase starts the leukotriene pathway from arachidonic acid.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Biochemistry questions
- Nucleotide metabolismA 4-year-old boy has intellectual disability, dystonia, self-mutilation and hyperuricaem…
- VitaminsA patient with megaloblastic anaemia and mild neurological signs has raised serum methyl…
- Amino acid metabolismA baby has a mousy odour, fair skin and developmental delay. Which enzyme is deficient?
- Glycogen storage diseasesA child has severe fasting hypoglycaemia, hepatomegaly, lactic acidosis and hyperuricaem…